3-Hydroxy-1-methyl-5-((methyl(phenyl)amino)methyl)-1H-pyrazole-4-carboxylic acid

ID: ALA4451149

PubChem CID: 155522278

Max Phase: Preclinical

Molecular Formula: C13H15N3O3

Molecular Weight: 261.28

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(Cc1c(C(=O)O)c(O)nn1C)c1ccccc1

Standard InChI:  InChI=1S/C13H15N3O3/c1-15(9-6-4-3-5-7-9)8-10-11(13(18)19)12(17)14-16(10)2/h3-7H,8H2,1-2H3,(H,14,17)(H,18,19)

Standard InChI Key:  WKFNJMDGGOCESI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
   31.8630  -10.6941    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.5260  -10.2162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2716   -9.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4544   -9.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2000  -10.2162    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9778   -9.0241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9747   -8.2069    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.9743   -8.7740    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.6870   -9.4300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3028  -10.4699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4715  -11.2694    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.2483  -11.5231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8634  -11.8153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8630  -11.5113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4132  -12.3205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1892  -12.5743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7982  -12.0281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6260  -11.2249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8503  -10.9749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  5  2  0
  2  3  2  0
  1  2  1  0
  3  4  1  0
  5  1  1  0
  3  6  1  0
  6  7  2  0
  4  8  1  0
  6  9  1  0
  2 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
  1 14  1  0
 12 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 12  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4451149

    ---

Associated Targets(Human)

DHODH Tclin Dihydroorotate dehydrogenase (2737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

COS-7 (515 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dhod Dihydroorotate dehydrogenase (710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 261.28Molecular Weight (Monoisotopic): 261.1113AlogP: 1.46#Rotatable Bonds: 4
Polar Surface Area: 78.59Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.07CX Basic pKa: 1.45CX LogP: 2.60CX LogD: -2.10
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.87Np Likeness Score: -1.03

References

1. Pippione AC, Sainas S, Goyal P, Fritzson I, Cassiano GC, Giraudo A, Giorgis M, Tavella TA, Bagnati R, Rolando B, Caing-Carlsson R, Costa FTM, Andrade CH, Al-Karadaghi S, Boschi D, Friemann R, Lolli ML..  (2019)  Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies.,  163  [PMID:30529545] [10.1016/j.ejmech.2018.11.044]

Source